[1] |
Connolly SA, Jardetzky TS, Longnecker R. The structural basis of herpesvirus entry[J]. Nat Rev Microbiol, 2021, 19(2):110-121.
doi: 10.1038/s41579-020-00448-w
pmid: 33087881
|
[2] |
Ahmad I, Wilson DW. HSV-1 cytoplasmic envelopment and egress[J]. Int J Mol Sci, 2020, 21(17):5969.
doi: 10.3390/ijms21175969
URL
|
[3] |
柳蕾. HSV-2突变株的构建及其生物学特性分析[D]. 北京: 中国医学科学院北京协和医学院, 2020.
|
[4] |
Gupta R, Warren T, Wald A. Genital herpes[J]. Lancet, 2007, 370(9605):2127-2137.
doi: 10.1016/S0140-6736(07)61908-4
pmid: 18156035
|
[5] |
Martinelli E, Tharinger H, Frank I, et al. HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target[J]. PLoS Pathog, 2011, 7(6):e1002109.
|
[6] |
Wang KN, Kappel JD, Canders C, et al. A Herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM[J]. J Virol, 2012, 86(23):12891-12902.
doi: 10.1128/JVI.01055-12
pmid: 22993162
|
[7] |
Vahlne A, Svennerholm B, Sandberg M, et al. Differences in attachment between Herpes simplex type 1 and type 2 viruses to neurons and glial cells[J]. Infect Immun, 1980, 28(3):675-680.
doi: 10.1128/iai.28.3.675-680.1980
pmid: 6249749
|
[8] |
Gupta A, Rani PK, Bagga B, et al. Bilateral Herpes simplex-2 acute retinal necrosis with encephalitis in premature twins[J]. J AAPOS, 2010, 14(6):541-543.
doi: 10.1016/j.jaapos.2010.08.011
pmid: 21168079
|
[9] |
Miller S, Mateen FJ, Aksamit AJ Jr. Herpes simplex virus 2 meningitis: a retrospective cohort study[J]. J Neurovirol, 2013, 19(2):166-171.
doi: 10.1007/s13365-013-0158-x
pmid: 23494382
|
[10] |
代文文. 肠道病毒71型及单纯性疱疹病毒2型的抗病毒药物的作用研究[D]. 长春: 吉林大学, 2018.
|
[11] |
Matthews JT, Terry BJ, Field AK. The structure and function of the HSV DNA replication proteins: defining novel antiviral targets[J]. Antiviral Res, 1993, 20(2):89-114.
doi: 10.1016/0166-3542(93)90001-Y
URL
|
[12] |
顾莹莹. 阿昔洛韦的临床应用[J]. 中国现代药物应用, 2013, 7(20):120-121.
|
[13] |
Collot M, Rouard C, Brunet C, et al. High conservation of Herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies[J]. Antiviral Res, 2016, 128:1-6.
doi: 10.1016/j.antiviral.2016.01.015
URL
|
[14] |
Rafique G, Bukhsh A, Gul A, et al. Hematologic adverse effects and efficacy monitoring in chronic Hepatitis C patients treated with interferon and ribavirin combination therapy[J]. Pak J Pharm Sci, 2017, 30(1):11-16.
pmid: 28603106
|
[15] |
侯盼飞, 江新泉, 赵英会. 紫草的抗病毒作用研究进展[J]. 泰山医学院学报, 2007, 28(3):239-240.
|
[16] |
罗学娅, 李明辉, 伦永志, 等. 左旋紫草素抗副流感病毒作用[J]. 中草药, 2005, 36(4):568-571.
|
[17] |
Chen X, Yang L, Zhang N, et al. Shikonin, a component of Chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1[J]. Antimicrob Agents Chemother, 2003, 47(9):2810-2816.
doi: 10.1128/AAC.47.9.2810-2816.2003
pmid: 12936978
|
[18] |
Liu X, Zhang XC, Li J, et al. Effects of acetylshikonin on the infection and replication of coxsackievirus A16 in vitro and in vitro[J]. J Nat Prod, 2019, 82(5):1089-1097.
doi: 10.1021/acs.jnatprod.8b00735
URL
|
[19] |
Bernstein DI, Cardin RD, Smith GA, et al. The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model[J]. NPJ Vaccines, 2020, 5(1):104.
doi: 10.1038/s41541-020-00254-8
pmid: 33298966
|
[20] |
Huang HY, Wen Y, Valbuena D, et al. Interleukin 1 beta regulates Vero cell interleukin-1 receptor type I messenger ribonucleic acid expression[J]. Biol Reprod, 1997, 57(4):783-790.
pmid: 9314581
|
[21] |
李涛, 李媛, 陈钰, 等. 人参及其复方制剂防治肺病的研究进展[J]. 中草药, 2021, 52(17):5339-5349.
|
[22] |
Gao H, Liu L, Qu ZY, et al. Anti-adenovirus activities of shikonin, a component of Chinese herbal medicine in vitro[J]. Biol Pharm Bull, 2011, 34(2):197-202.
pmid: 21415527
|
[23] |
Zhang Y, Han H, Sun L, et al. Antiviral activity of shikonin ester derivative PMM-034 against enterovirus 71 in vitro[J]. Brai J Med Biol Res, 2017, 50(10):e6586.
|
[24] |
万明明. 以包膜糖蛋白gB/D为抗原的2型单纯疱疹病毒新型疫苗的研究[D]. 长春: 吉林大学, 2019.
|